For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| BIA 2-093 800 mg Fasting | Tablets 800 mg. Administration:Oral. BIA 2-093 | None | None | 0 | 18 | 3 | 18 | View |
| BIA 2-093 800 mg Fed | Tablets 800 mg. Administration:Oral. BIA 2-093 | None | None | 0 | 17 | 2 | 17 | View |
| BIA 2-093 800 mg (2 x 400 mg) | Tablets 2 x 400 mg. Administration:Oral. BIA 2-093 | None | None | 0 | 17 | 2 | 17 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Diarrhoea | None | Gastrointestinal disorders | MedDRA 10.0 | View |
| Tonsillitis | None | Infections and infestations | MedDRA 10.0 | View |
| CPK increased | None | Investigations | MedDRA 10.0 | View |
| Somnolence | None | Nervous system disorders | MedDRA 10.0 | View |
| Pregnancy | None | Pregnancy, puerperium and perinatal conditions | MedDRA 10.0 | View |
| Tooth extraction | None | Surgical and medical procedures | MedDRA 10.0 | View |